Related Experiment Video
Updated: Sep 18, 2025

Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes
Published on: January 12, 2024
Molecular features defining the efficiency of bioPROTACs
Dorothea Winkelvoß1, David Vukovic1, Anna-Carina Hänny1
1Department of Biochemistry, University of Zurich, Zurich, Switzerland.
Researchers explored bioPROTACs, revealing that optimal target ubiquitination and proteasome presentation, not just binding affinity, are key for efficient protein degradation. This study provides design principles for optimizing bioPROTAC systems.
Area of Science:
- Biochemistry
- Molecular Biology
- Proteomics
Background:
- BioPROTACs (biological Proteolysis-Targeting Chimeras) leverage target-binding moieties and ubiquitin-proteasome system (UPS) components for protein degradation.
- Understanding the biophysical design principles of the target-binding unit is crucial for enhancing bioPROTAC efficacy.
- Current knowledge on factors influencing bioPROTAC performance remains limited.
Purpose of the Study:
- To investigate the design principles governing the target-binding moiety of bioPROTACs.
- To identify key factors influencing the efficiency of protein degradation mediated by bioPROTACs.
- To establish strategies for characterizing and optimizing bioPROTAC systems.
Main Methods:
- Utilized a novel assay employing microinjection and live-cell microscopy to accurately measure protein degradation rates, independent of biosynthesis and transport.
- Employed DARPins (Designed Ankyrin Repeat Proteins) as target-binding units and a CHIP E3 ligase interaction domain.
- Tested the degradation of enhanced green fluorescent protein (eGFP) as a proof-of-principle target.
Main Results:
- Most DARPins effectively facilitated eGFP degradation, with two exceptions due to steric hindrance of E2 binding or overlap with the ubiquitination epitope.
- The affinity and thermodynamic stability of binders played a minor role in degradation efficiency.
- Constructed bioPROTACs demonstrated catalytic degradation of eGFP.
- DARPins alone accelerated GFP degradation non-catalytically via endogenous E3 ligases.
Conclusions:
- Efficient trans-acting bioPROTAC degradation critically depends on the correct complex orientation for target ubiquitination and proteasome presentation, requiring empirical determination.
- The developed strategies offer a robust pathway for characterizing and optimizing bioPROTAC design and function.
- BioPROTACs can achieve catalytic protein degradation, offering a powerful tool for molecular manipulation.
More Related Videos
08:31Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
05:33High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines
Published on: November 9, 2020
Related Concept Videos
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
Catalytically Perfect Enzymes
Most enzymes...
Prodrugs
Prodrugs help overcome...
Drug Biotransformation: Overview
Antimicrobial Effectiveness
Turnover Number and Catalytic Efficiency
Chymotrypsin is a pancreatic enzyme that breaks down proteins during digestion....